Personalized monitor plan for Pancreatic Cancer with Valsartan
At this moment, we are studying 30,054 people who take Valsartan.
Do you have Pancreatic cancer while taking Valsartan? Don't worry. By subscribing to our personalized side effect monitoring plan, you get an analysis report that is personalized to your gender and age each week. The report will include:
- time on the drug
- top conditions
- top co-used drugs
- top other side effects
- severity of Pancreatic cancer with Valsartan (least/moderate/severe/most severe)*
- how people recovered from Pancreatic cancer with Valsartan (while on drug/after off the drug/not yet)*
* Results are not calculated from FDA reports, and are available only when data is present.
Monitoring plan subscription fee: $100.00 / year. The plan can be canceled anytime and be refunded prorately.
Please complete the payment form below to start your subscription.